Gene patenting isn't just a big case in the US: Australia's Full Federal Court is also considering the validity of patents held by Myriad Genetics and Genetic Technologies, a Melbourne-based firm, on isolated gene sequences associated with breast and ovarian cancers, ScienceInsider reports.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Guideline Change

Not Too Natural, Now

A New Lure

Play the Game

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.